已收盘 03-27 16:00:00 美东时间
-0.140
-1.24%
今日重点评级关注:HC Wainwright & Co.:维持BridgeBio Oncology"买入"评级,目标价从27美元升至29美元;韦德布什:维持WAVE Life Sciences"跑赢大市"评级,目标价从33美元升至35美元
03-09 11:47
Barclays analyst Manav Patnaik upgrades First Advantage (NASDAQ:FA) from Equal-Weight to Overweight and raises the price target from $14 to $15.
03-06 21:45
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
Q4净利暴增超68%!Sezzle大涨超35%;GigaCloud业绩表现亮眼,大健云仓涨超33%>>
02-27 19:46
Gainers New Century Logistics (NASDAQ:NCEW) stock moved upwards by 20.4% to $9...
02-27 01:05
First Advantage shares are trading higher after the company reported better-tha...
02-26 23:26
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
First Advantage (NASDAQ:FA) is looking for FY2026 Adj EPS of $1.15-$1.25 vs $1.19 analyst estimate. sees sales of $1.625 billion-$1.700 billion vs $1.623 billion analyst estimate.
02-26 19:03
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 10:22